Reserve mechanisms in neurodegenerative diseases: From bench to bedside and back again

B. Borroni, E. Premi, M. Bozzali, A. Padovani

Research output: Contribution to journalArticle

Abstract

In the course of neurodegenerative disorders there are several mechanisms that may counteract the pathological process, mitigating the clinical manifestations of the disease. Usually referred as cognitive reserve hypothesis, this theoretical framework posits that individuals with enriched cognitive status (i.e. with higher educational and occupational levels and higher individual social achievement) may cope better with the occurrence of cognitive decline by a more efficient recruitment of neural networks sustaining higher-level functions. Cognitive reserve was initially studied in Alzheimer's disease, but this concept has been soon after extended also to other neurodegenerative disorders, such as Frontotemporal Dementia, Parkinson's disease, and Huntington's disease, suggesting a general applicability of cortical plasticity phenomena in contrasting neurodegeneration. The neural underpinnings of these dynamic compensatory mechanisms open the possibility for strategic interventions based on environmental approaches. In this continuously growing field, the aim of the present review is to explore new acquisitions, derived from basic research and clinical grounds, on cognitive reserve mechanisms and the potential application as novel therapeutic targets in neurodegenerative diseases.

Original languageEnglish
Pages (from-to)6112-6118
Number of pages7
JournalCurrent Medicinal Chemistry
Volume19
Issue number36
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Cognitive Reserve
Neurodegenerative diseases
Neurodegenerative Diseases
Frontotemporal Dementia
Huntington Disease
Pathologic Processes
Parkinson Disease
Alzheimer Disease
Plasticity
Neural networks
Research
Therapeutics

Keywords

  • Alzheimer's disease
  • Cognitive reserve
  • Education
  • Frontotemporal Dementia
  • Frontotemporal lobar degeneration
  • MRI
  • Neurodegenerative disease
  • Occupation
  • PET
  • Reserve mechanisms

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Reserve mechanisms in neurodegenerative diseases : From bench to bedside and back again. / Borroni, B.; Premi, E.; Bozzali, M.; Padovani, A.

In: Current Medicinal Chemistry, Vol. 19, No. 36, 12.2012, p. 6112-6118.

Research output: Contribution to journalArticle

Borroni, B. ; Premi, E. ; Bozzali, M. ; Padovani, A. / Reserve mechanisms in neurodegenerative diseases : From bench to bedside and back again. In: Current Medicinal Chemistry. 2012 ; Vol. 19, No. 36. pp. 6112-6118.
@article{af24171dbd9b4b47b085726ac403eaff,
title = "Reserve mechanisms in neurodegenerative diseases: From bench to bedside and back again",
abstract = "In the course of neurodegenerative disorders there are several mechanisms that may counteract the pathological process, mitigating the clinical manifestations of the disease. Usually referred as cognitive reserve hypothesis, this theoretical framework posits that individuals with enriched cognitive status (i.e. with higher educational and occupational levels and higher individual social achievement) may cope better with the occurrence of cognitive decline by a more efficient recruitment of neural networks sustaining higher-level functions. Cognitive reserve was initially studied in Alzheimer's disease, but this concept has been soon after extended also to other neurodegenerative disorders, such as Frontotemporal Dementia, Parkinson's disease, and Huntington's disease, suggesting a general applicability of cortical plasticity phenomena in contrasting neurodegeneration. The neural underpinnings of these dynamic compensatory mechanisms open the possibility for strategic interventions based on environmental approaches. In this continuously growing field, the aim of the present review is to explore new acquisitions, derived from basic research and clinical grounds, on cognitive reserve mechanisms and the potential application as novel therapeutic targets in neurodegenerative diseases.",
keywords = "Alzheimer's disease, Cognitive reserve, Education, Frontotemporal Dementia, Frontotemporal lobar degeneration, MRI, Neurodegenerative disease, Occupation, PET, Reserve mechanisms",
author = "B. Borroni and E. Premi and M. Bozzali and A. Padovani",
year = "2012",
month = "12",
doi = "10.2174/092986712804485737",
language = "English",
volume = "19",
pages = "6112--6118",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "36",

}

TY - JOUR

T1 - Reserve mechanisms in neurodegenerative diseases

T2 - From bench to bedside and back again

AU - Borroni, B.

AU - Premi, E.

AU - Bozzali, M.

AU - Padovani, A.

PY - 2012/12

Y1 - 2012/12

N2 - In the course of neurodegenerative disorders there are several mechanisms that may counteract the pathological process, mitigating the clinical manifestations of the disease. Usually referred as cognitive reserve hypothesis, this theoretical framework posits that individuals with enriched cognitive status (i.e. with higher educational and occupational levels and higher individual social achievement) may cope better with the occurrence of cognitive decline by a more efficient recruitment of neural networks sustaining higher-level functions. Cognitive reserve was initially studied in Alzheimer's disease, but this concept has been soon after extended also to other neurodegenerative disorders, such as Frontotemporal Dementia, Parkinson's disease, and Huntington's disease, suggesting a general applicability of cortical plasticity phenomena in contrasting neurodegeneration. The neural underpinnings of these dynamic compensatory mechanisms open the possibility for strategic interventions based on environmental approaches. In this continuously growing field, the aim of the present review is to explore new acquisitions, derived from basic research and clinical grounds, on cognitive reserve mechanisms and the potential application as novel therapeutic targets in neurodegenerative diseases.

AB - In the course of neurodegenerative disorders there are several mechanisms that may counteract the pathological process, mitigating the clinical manifestations of the disease. Usually referred as cognitive reserve hypothesis, this theoretical framework posits that individuals with enriched cognitive status (i.e. with higher educational and occupational levels and higher individual social achievement) may cope better with the occurrence of cognitive decline by a more efficient recruitment of neural networks sustaining higher-level functions. Cognitive reserve was initially studied in Alzheimer's disease, but this concept has been soon after extended also to other neurodegenerative disorders, such as Frontotemporal Dementia, Parkinson's disease, and Huntington's disease, suggesting a general applicability of cortical plasticity phenomena in contrasting neurodegeneration. The neural underpinnings of these dynamic compensatory mechanisms open the possibility for strategic interventions based on environmental approaches. In this continuously growing field, the aim of the present review is to explore new acquisitions, derived from basic research and clinical grounds, on cognitive reserve mechanisms and the potential application as novel therapeutic targets in neurodegenerative diseases.

KW - Alzheimer's disease

KW - Cognitive reserve

KW - Education

KW - Frontotemporal Dementia

KW - Frontotemporal lobar degeneration

KW - MRI

KW - Neurodegenerative disease

KW - Occupation

KW - PET

KW - Reserve mechanisms

UR - http://www.scopus.com/inward/record.url?scp=84871281652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871281652&partnerID=8YFLogxK

U2 - 10.2174/092986712804485737

DO - 10.2174/092986712804485737

M3 - Article

C2 - 23072353

AN - SCOPUS:84871281652

VL - 19

SP - 6112

EP - 6118

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 36

ER -